| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 0.1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |